Treating Treatment-Resistant Obsessive-Compulsive Disorder (OCD) via Deep Brain Stimulation (DBS)

Authors

  • Wing Hei Wong

DOI:

https://doi.org/10.62051/nthr1d46

Keywords:

Deep brain stimulation; Treatment-resistant obsessive-compulsive disorder; Subthalamic nucleus (STN); Bed nucleus of the stria terminalis (BNST).

Abstract

Obsessive-Compulsive Disorder (OCD) is a prevalent and challenging mental health condition characterized by persistent, unwanted thoughts (obsessions) and repetitive behaviors (compulsions). Traditional treatment modalities, including pharmacotherapy and cognitive-behavioral therapies, fail to alleviate symptoms in around half of the patients, necessitating the exploration of alternative therapeutic options. Deep Brain Stimulation (DBS) has emerged as a promising intervention for treatment-resistant OCD, with recent studies reporting a success rate of about 60%. This innovative treatment involves the precise placement of electrodes in specific brain regions such as the Nucleus Accumbens (NAcc), Bed Nucleus of the Stria Terminalis (BNST), and Subthalamic Nucleus (STN) to modulate dysfunctional neural circuits. This paper reviews the effectiveness of DBS in reducing OCD symptoms, evaluates its safety, and discusses the neurobiological mechanisms underlying its therapeutic effects. It also explores future research directions, including the optimization of electrode placement, the integration of DBS with other treatment modalities, and the development of personalized medicine approaches. Furthermore, the paper addresses ongoing challenges such as the need for a clearer understanding of DBS mechanisms, the refinement of patient selection criteria, and the management of long-term outcomes. By providing a comprehensive overview of current knowledge and potential developments, this study aims to highlight the role of DBS as a transformative tool for managing severe, refractory OCD.

Downloads

Download data is not yet available.

References

[1] Liberman, N., Lazarov, A., & Dar, R. (2023). Obsessive-Compulsive Disorder: The Underlying Role of Diminished Access to Internal States. Current Directions in Psychological Science, 32 (2), 118 – 124. https: //doi.org/10.1177/09637214221128560.

[2] Stein, D. J., Costa, D. L. C., Lochner, C., Miguel, E. C., Reddy, Y. C. J., Shavitt, R. G., Van Den Heuvel, O. A., & Simpson, H. B. (2019). Obsessive–compulsive disorder. Nature Reviews Disease Primers, 5 (1). https: //doi.org/10.1038/s41572 - 019 - 0102 - 3.

[3] Obsessive-Compulsive Disorder (OCD). (n.d.). National Institute of Mental Health (NIMH). https: //www.nimh.nih.gov/health/statistics/obsessive-compulsive-disorder-ocd.

[4] Pigott, T. A., & Seay, S. M. (1999). A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Journal of Clinical Psychiatry, 60 (2), 101 - 106. Reddy, Y. J., Sundar, A., Narayanaswamy, J., & Math, S. (2017). Clinical practice guidelines for obsessive-compulsive disorder. Indian Journal of Psychiatry, 59 (5), 74. https: //doi.org/10.4103/0019 - 5545.196976.

[5] Kayser, R. R. (2020). Pharmacotherapy for Treatment-Resistant Obsessive-Compulsive Disorder. The Journal of Clinical Psychiatry, 81(5). https://doi.org/10.4088/jcp.19ac13182.

[6] Pharmacotherapy. (n.d.). Obsessive-Compulsive and Related Disorders. https: //med.stanford.edu/ocd/treatment/pharma.html#: ~:text=Over%2010%2D12%20weeks%2C%20symptoms, another%20or%20to%20behavior%20therapy.

[7] Simpson, H., & Hezel, D. (2019). Exposure and response prevention for obsessive-compulsive disorder: A review and new directions. Indian Journal of Psychiatry, 61 (7), 85. https: //doi.org/10.4103/psychiatry.indianjpsychiatry_516_18.

[8] Zrinzo, L. (2024). Severe refractory obsessive-compulsive disorder and depression: Should we consider stereotactic neurosurgery? Neuropsychiatric Disease and Treatment, Volume 20, 469 – 478. https: //doi.org/10.2147/ndt.s407210.

[9] Mar-Barrutia, L., Real, E., Segalás, C., Bertolín, S., Menchón, J. M., & Alonso, P. (2021). Deep brain stimulation for obsessive-compulsive disorder: A systematic review of worldwide experience after 20 years. World Journal of Psychiatry, 11 (9), 659 – 680. https: //doi.org/10.5498/wjp.v11.i9.659.

[10] Tjelle, K., Opstad, H. B., Solem, S., Kvale, G., Wheaton, M. G., Björgvinsson, T., Hansen, B., & Hagen, K. (2024). Patient adherence as a predictor of acute and long-term outcomes in concentrated exposure treatment for difficult-to-treat obsessive-compulsive disorder. BMC Psychiatry, 24 (1). https: //doi.org/10.1186/s12888 - 024 - 05780 - 6.

[11] Naesström, M., Hariz, M., Strömsten, L., Bodlund, O., & Blomstedt, P. (2021). Deep Brain Stimulation in the Bed Nucleus of Stria Terminalis in Obsessive-Compulsive Disorder—1-Year Follow-up. World Neurosurgery, 149, e794 – e802. https://doi.org/10.1016/j.wneu.2021.01.097.

[12] Philipson, J., Naesstrom, M., Johansson, J. D., Hariz, M., Blomstedt, P., & Jahanshahi, M. (2022). Deep brain stimulation in the ALIC-BNST region targeting the bed nucleus of stria terminalis in patients with obsessive–compulsive disorder: effects on cognition after 12 months. Acta Neurochirurgica, 165 (5), 1201 – 1214. https: //doi.org/10.1007/s00701 - 022 - 05351 - 2.

[13] Raviv, N., Staudt, M. D., Rock, A. K., MacDonell, J., Slyer, J., & Pilitsis, J. G. (2020). A Systematic review of Deep Brain stimulation Targets for Obsessive Compulsive Disorder. Neurosurgery, 87(6), 1098–1110. https://doi.org/10.1093/neuros/nyaa249.

[14] Tyagi, H., Apergis-Schoute, A. M., Akram, H., Foltynie, T., Limousin, P., Drummond, L. M., Fineberg, N. A., Matthews, K., Jahanshahi, M., Robbins, T. W., Sahakian, B. J., Zrinzo, L., Hariz, M., & Joyce, E. M. (2019b). A randomized trial directly comparing ventral capsule and anteromedial subthalamic nucleus stimulation in obsessive-compulsive disorder: clinical and imaging evidence for dissociable effects. Biological Psychiatry, 85 (9), 726 – 734. https: //doi.org/10.1016/j.biopsych.2019.01.017.

[15] Chabardès, S., Polosan, M., Krack, P., Bastin, J., Krainik, A., David, O., Bougerol, T., & Benabid, A. L. (2013). Deep Brain Stimulation for Obsessive-Compulsive Disorder: Subthalamic Nucleus Target. World Neurosurgery, 80 (3–4), S31.e1-S31.e8. https://doi.org/10.1016/j.wneu.2012.03.010

[16] Mallet, L., Polosan, M., Jaafari, N., Baup, N., Welter, M. L., Fontaine, D., Du Montcel, S. T., Yelnik, J., Chéreau, I., Arbus, C., Raoul, S., Aouizerate, B., Damier, P., Chabardès, S., Czernecki, V., Ardouin, C., Krebs, M. O., Bardinet, E., Chaynes, P., . . . Pelissolo, A. (2008). Subthalamic Nucleus Stimulation in Severe Obsessive–Compulsive Disorder. New England Journal of Medicine, 359 (20), 2121 – 2134. https: //doi.org/10.1056/nejmoa0708514.

[17] Neuron | Vol 112, Issue 1, Pages 1-174 (3 January 2024) | ScienceDirect.com by Elsevier. (n.d.). https://www.sciencedirect.com/journal/neuron/vol/112/issue/1.

[18] Elsouri, K. N., Heiser, S. E., Cabrera, D., Alqurneh, S., Hawat, J., & Demory, M. L. (2024). Management and Treatment of Obsessive-Compulsive Disorder (OCD): a literature review. Cureus. https: //doi.org/10.7759/cureus.60496.

[19] Royal Australian and New Zealand College of Psychiatrists, R. (2022). Deep Brain Stimulation (DBS) in psychiatric practice. In Clinical Memorandum. https: //www.ranzcp.org/getmedia/6c0ed4ce-7520-4914-afb3-e08911825ed6/cm-deep-brain-stimulation-in-psychiatric-practice.pdf.

[20] Greenberg, B. D., Gabriels, L. A., Malone, D. A., Rezai, A. R., Friehs, G. M., Okun, M. S., Shapira, N. A., Foote, K. D., Cosyns, P. R., Kubu, C. S., Malloy, P. F., Salloway, S. P., Giftakis, J. E., Rise, M. T., Machado, A. G., Baker, K. B., Stypulkowski, P. H., Goodman, W. K., Rasmussen, S. A., & Nuttin, B. J. (2008). Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Molecular Psychiatry, 15 (1), 64 – 79. https: //doi.org/10.1038/mp.2008.55.

[21] Pepper, J., Zrinzo, L., Mirza, B., Foltynie, T., Limousin, P., & Hariz, M. (2012). The Risk of Hardware Infection in Deep Brain Stimulation Surgery Is Greater at Impulse Generator Replacement than at the Primary Procedure. Stereotactic and Functional Neurosurgery, 91 (1), 56 – 65. https: //doi.org/10.1159/000343202.

[22] D’Imperio, A., & Ienca, M. (2024). Deep brain stimulation and suicide attempts in treatment-resistant patients: a case report and neuroethical analysis. Frontiers in Psychiatry, 15. https: //doi.org/10.3389/fpsyt.2024.1398777.

[23] Abdelnaim, M. A., Lang-Hambauer, V., Hebel, T., Schoisswohl, S., Schecklmann, M., Deuter, D., Schlaier, J., & Langguth, B. (2023). Deep brain stimulation for treatment resistant obsessive compulsive disorder; an observational study with ten patients under real-life conditions. Frontiers in Psychiatry, 14. https: //doi.org/10.3389/fpsyt.2023.1242566.

[24] De Koning, P. P. (2016). Rapid mechanisms of DBS in OCD. https: //pure.uva.nl/ws/files/2735940/177462_Koning_thesis_complete.pdf.

[25] Fenoy, A. J., & Simpson, R. K. (2014). Risks of common complications in deep brain stimulation surgery: management and avoidance. Journal of Neurosurgery, 120(1), 132–139. https://doi.org/10.3171/2013.10.jns131225.

[26] Graat, I., Mocking, R., Figee, M., Vulink, N., De Koning, P., Ooms, P., Mantione, M., Van Den Munckhof, P., Schuurman, R., & Denys, D. (2021). Long-term Outcome of Deep Brain Stimulation of the Ventral Part of the Anterior Limb of the Internal Capsule in a Cohort of 50 Patients with Treatment-Refractory Obsessive-Compulsive Disorder. Biological Psychiatry, 90 (10), 714 – 720. https://doi.org/10.1016/j.biopsych.2020.08.018.

[27] Transcranial magnetic stimulation (TMS) in treating OCD. (1970, January 1). Top Doctors. https: //www.topdoctors.co.uk/medical-articles/transcranial-magnetic-stimulation-tms-in-treating-ocd.

[28] Lai, Y., Wang, T., Zhang, C., Lin, G., Voon, V., Chang, J., & Sun, B. (2020). Effectiveness and safety of neuroablation for severe and treatment-resistant obsessive–compulsive disorder: a systematic review and meta-analysis. Journal of Psychiatry and Neuroscience, 45 (5), 356 – 369. https: //doi.org/10.1503/jpn.190079.

[29] Mantione, M., Nieman, D. H., Figee, M., & Denys, D. (2014). Cognitive–behavioral therapy augments the effects of deep brain stimulation in obsessive–compulsive disorder. Psychological Medicine, 44 (16), 3515 – 3522. https: //doi.org/10.1017/s0033291714000956.

Downloads

Published

24-12-2024

How to Cite

Wong, W. H. (2024). Treating Treatment-Resistant Obsessive-Compulsive Disorder (OCD) via Deep Brain Stimulation (DBS). Transactions on Materials, Biotechnology and Life Sciences, 7, 557-565. https://doi.org/10.62051/nthr1d46